ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001366.1|BE-24566B_1 # 11 # 274 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0001366.1|BE-24566B_1 	11	274	-	Loose	750	23.483	adeF	32.56	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGACGACGATGCGACGCCGTTCTCTCTCGCAGCCGAGCAGAGCGCTGGACCGGAGCACCGCGGGCGGCGAAACGCTCCATCAAAGCACCTGTGTGCCCATCTACGCCGCCCTGGTCGAGCGCTGGGCCTCCGCGGGCCGGGCCGTGCCGGGGCGCTACGACCGGGAGTGGGCCGAGCTGGTGAACTGCCCGCCCTGGCCCGAGCGGGTCCGCTCCGCCTCCCGGCCCGCCACCTCCCCGGCGCCCCTCAAGCGCTCCTGA	MTTTMRRRSLSQPSRALDRSTAGGETLHQSTCVPIYAALVERWASAGRAVPGRYDREWAELVNCPPWPERVRSASRPATSPAPLKRS	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	8.22	gnl|BL_ORD_ID|132|hsp_num:0	153			1578	1707	tetracycline
BGC0001366.1|BE-24566B_2 # 681 # 2492 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.719	BGC0001366.1|BE-24566B_2 	681	2492	+	Loose	400	29.6462	vanR gene in vanD cluster	29.23	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAGGTTTCAGGTTCTGGGAAACTTCGAAGTCCTGAGCGACACCCGCGCCCGGACGCCGAGCGCTCCCAAGCTCCGCCGGGCCCTGGCCCTGCTGATACTGCGGCACAACGAGGTCGTGCCCACCAAGGCCCTCATCGACGAACTCTGGGGAAGCCGGCCCCCGGACAAAGCCATTCGGGCTGTACACACCTACATCTATGAACTCCGCCGCAGCCTGGCCCGCCCGGGCGGTGGCGGAGAGCTGTTCCTCCAGACCCGGCCGAGCGGCTATACCGTTCGCGTACCGGAAAGCGCGATCGACCTCAATTCCTTTCGAGTCCTGGTCAAAGAGGGCAGGGAGGCGCTTGCTGCGGGGGACCCGGGACACGCCCGGGAAGTGCTGAACCGGGCCCTGGGGCTGTGGCAGGGCAGCGCCCTGGCCAATGTGGACTGCGGGGAACTGCTCGAAGCGCATGCGACCGAGCTGGAGGAGAGCCGGCTGCGTGCCCTGGAGATGCGCATCGAAGCCGATTTCCAACTCAGCCGGCACCATGAATTGACCGGTGAGCTCAAGGCGCTGGCCGCCGCCAGGCCCCTGCACGAGGGCATCCACGCCAAACTGATGCTCGCGCTCTACCGTTCGGGGCGGCGCGGCGAGGCGCTCAAGGTCTTCCACGACCTGCGCCGCCATCTGGTCGACGAGCTGGGCCTGGAGCCGGGCCCCGAGCTCCAGCGGCTGCAGCGCTCCATGCTCGCCGGGGACCCCTCGCTCGACCCGCCGACCGCGCCACCGCTCCCGCCGCCCCGCCGCGCGCAGCCCCCGGCACCGCCCGCCCAGCTCCCCCGGGACACCGTCGACTTCACCGGGCGGCAGGCCGTGCTCGACGAGGTCGGCGCCCTGCTCGCGCCCCACGGCGACGGCACGGGCCTGCCCGTGGTGTCGCTGGTCGGCATGCCGGGCGTCGGCAAGACGGCCACCGCCATCCACCTCGCCCACGCGGTCCGCGCCCGCTACCCCGACGGGCAGCTGTACGTACCGCTGGGCGGATCGCAGCCCACTCCGGCGACCGCGGCGGAGGGGATGGAACACATTCTGCGGGGGATCGGTGTGGCGCCGCGCGACATCCCGAGCACGCTGGGCGGGCGGATGGCCCTGTTCCGCACCTGGAGCTCCGACCGCCGGGTGCTGCTGGTACTGGACGACGCCGACTCGCCGCAGCAGGTCGAACCGCTGCTCCCGGGCGGCACCGGCTGCGCCGTGCTGATCACCGGCCGCTCCCTGCTGTACGGGCTGCGCGGGGCGCGGACCATCGCGCTGAGCTGCCTGTCCACCGCGGAGGGCGGGCAGCTGCTCACCCGGCTGATCGGGCGGGAGCGGACGGACGCCGAGCCCGAGGCCGTCGCCGATGTGGTGCGGCTGGCGGACGGTCTGCCGCTGGCCATCACCTTCCTCGGCGAGCGGCTGATGGCGTTGCGGCCGGTCAGTATCGCCTGCGTGCTGGCGAAGATACGATCCGCCAAGGGGCAGCACCGGCTCTCCGAGCTCTCGGCGCTGGGGCTCGACCTGTACGACCGGCTGGACAGCTGCTTCCGCAAGCTCGACGAGAACACGCAGCAGGCCTTTCTGCGGCTGGCCCTGATGCCGCGCCGGCTGTTCACCGCCGGGCAGGGCGCCCGTGCGCTGGGCACCGACACCACCTCGGCCGACGTGGTGCTCATGCGGCTGGTCGACGCCTCACTGGTGGAGGTCGCGGGGGAGCGGGAGGTGGGCGCGAGACACTACCGCTTCCGGGAACTGGTCCGCGAGTACGCGCTGGAGCGGATGGCGTGA	MRFQVLGNFEVLSDTRARTPSAPKLRRALALLILRHNEVVPTKALIDELWGSRPPDKAIRAVHTYIYELRRSLARPGGGGELFLQTRPSGYTVRVPESAIDLNSFRVLVKEGREALAAGDPGHAREVLNRALGLWQGSALANVDCGELLEAHATELEESRLRALEMRIEADFQLSRHHELTGELKALAAARPLHEGIHAKLMLALYRSGRRGEALKVFHDLRRHLVDELGLEPGPELQRLQRSMLAGDPSLDPPTAPPLPPPRRAQPPAPPAQLPRDTVDFTGRQAVLDEVGALLAPHGDGTGLPVVSLVGMPGVGKTATAIHLAHAVRARYPDGQLYVPLGGSQPTPATAAEGMEHILRGIGVAPRDIPSTLGGRMALFRTWSSDRRVLLVLDDADSPQQVEPLLPGGTGCAVLITGRSLLYGLRGARTIALSCLSTAEGGQLLTRLIGRERTDAEPEAVADVVRLADGLPLAITFLGERLMALRPVSIACVLAKIRSAKGQHRLSELSALGLDLYDRLDSCFRKLDENTQQAFLRLALMPRRLFTAGQGARALGTDTTSADVVLMRLVDASLVEVAGEREVGARHYRFRELVREYALERMA	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	259.91	gnl|BL_ORD_ID|1052|hsp_num:0	1004			498	690	vancomycin; teicoplanin
BGC0001366.1|BE-24566B_3 # 2568 # 3191 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=3-4bp;gc_cont=0.739	BGC0001366.1|BE-24566B_3 	2568	3191	-	Loose	500	27.335	ANT(3'')-Ib	34.18	3005062	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGGCGCGGAGGAAGCACCGGCGCCGCCGGTACGGACCCGTCGCAGGGGCGCGGCCCTGGAGCGGGCCATCTACAAGGCGACGATCGCCGAGTGCGCCGAACTGGGCTACGGCAGGCTGACGCTCAAGGGGGTCGCGGAACGGGCGCGCACCGGTAAGGCGGCGCTGTACCGCCGCTGGAGCACCCCGCAGGACCTGCTGCTCGACGCCTTCGAACATGTCCTGCTGCCCAGCGAGGAACTGCCCGAGACGGGCGATCTGCGCGAGGAACTGGTGGCGGCGCTGCGGCGGATGGCCGACTCGCTCACCGGCCGCACCGGCCCGCCCGCGATGGTGCTGCTGGGGGATCTGCTGCGCCACCCCGAGCTGATCGCGGTGTTCCGCACCCGGTTCATCGAGCCGCGGCTGGAGGCGATCGCGGAGATCCTGCGGCGGGCGGCCGAGCGCGGCGAGATCCCCGGGGAGTCGGCCGGCCCGTTCGCCGCGCGGACCGGGCCCGCGCAGGTGATGATGCACTATCTGCTCAACGGCACCCCGCCGGACGACCGGGCCATCGAGGCCATGGTCGACCAGGTGGTGCTACCCGCGCTGCGGGCCGGACACCGGGCCGCGGACACCACCTGA	MGAEEAPAPPVRTRRRGAALERAIYKATIAECAELGYGRLTLKGVAERARTGKAALYRRWSTPQDLLLDAFEHVLLPSEELPETGDLREELVAALRRMADSLTGRTGPPAMVLLGDLLRHPELIAVFRTRFIEPRLEAIAEILRRAAERGEIPGESAGPFAARTGPAQVMMHYLLNGTPPDDRAIEAMVDQVVLPALRAGHRAADTT	MPPPANEPVPAEVQPILDVVVRALGDDIAGAYLFGSAIAGGLRPDSDVDLLVLTHRTMSRQSREDLVAALMEVSGARAGRGPARNAEVTVVVLGDIAPWRHPARSDFVYGEWLRDDFAAGVVPAPTADPDLTLVLATALQSHRALMGPGLAEFLPAIPYADIRRAMADSLPGLVANVRGDERNVMLTLARMWVTVATGDIVPKDAAADWLLPRLPPERRALLATARDAYRGHVADEAWHECRADVSEWVSEVSQAIARTLHDSVKA	77.82	gnl|BL_ORD_ID|2787|hsp_num:0	3802			186	387	spectinomycin; streptomycin
BGC0001366.1|BE-24566B_4 # 3374 # 4846 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.756	BGC0001366.1|BE-24566B_4 	3374	4846	+	Loose	1000	213.001	efpA	35.24	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACGTCACCCAGGACCCCGCCCCGCCGCCCCGGTTCTGGTGGGCCATTCTGGTGATCGCGGGAGCGCAGCTGATGGTGGTGCTGGACATCAGCATCGTGAACATCGCGCTGCCCAGCATCCGCGACGACCTCGGCTTCACCCGGTCCGGGCTGCAGTGGGTGGTCAACGGCTACACCCTCGCCTTCGGCGGGCTGCTGCTGTTCGGCGGCCGGGTGGGCGATCTCCTGGGCCGCCGCCGGGTGTTCGCCTGCGGAGTCTGCGCGTTCGCACTGATCTCCCTGCTCGGCGGCTTCGCCGACGGGCCCGGCCGGCTCATCGCCGCCCGCGCCGCCCAGGGCGTGGCCGGCGCCCTCGTCGCGCCCACCGCCCTGGCGCTGATCAGCACGACCTTCCCGGAAGGGCGGCAGCGCCGCGCCGCGTTCGGCGTCTACGGGGCGGTGTCCGCGGGCGGCGGGGCTATCGGGCTGCTGCTGGGCGGGCTGCTCACCGACACCCTCTCCTGGCGCTGGGTGCTCTGGGTCAATGTGCCCATCGGCGCCGCGCTCGCCTGTGGCGCCCTGCTGGTGCTGCCCTCCTCCGCGCGCCGGGGCGGCCGGTTCGACCTGCCCGGGGCGCTCTCGGTCACCGGCGGGCTGACCGCGCTGGTGTACGGGCTGGTCCGCGCCCCCCAGCACGGCTGGGCCGACCGCTGGACGCTGACCTCGTTCGCCGCGGCGGCCGGGCTCCTGGTCCTGTTCGTGTTGATCGAGGTGCGCGGCCGGCAGCCGCTGATGCCGTTGCGCGTCTTCGCCGACCGCGACCGCTCCGGTGCCTACGCGGTGACCCTCCTGACCGGCGCGGCGCTGCTGAGCACGCTCTTCTTCCTCGCCCAGTTCGCGCAGGACGTGATGGGCTACTCACCGCTGCGCAACGGCGTGGCGTTCCTGCCCAACGCCGCCTGCGTGCTGCTCTTCTCCGGGCTCGCCGCACGGCTGACCGCCCGCGTCGGCGCCATGCCGCTGATGGCCGCGGGCGCCGCCTCGATGGCCCTCGGCCTGGCCTGGCTGTCGCGGCTCGACGTCGGCGCGAGGTACGCCGCCGACCTGCTGCCGGGCCTGCTGCTGTACGGGTCCGGCCTCGGCCTGCTGTTCGTACCGCTGTCCATGACCGCGGTCGCGACCGTCGCGGACGAGGACTCCGGCCTCGCCTCCGGGCTGCTCAACACCGCCCAGCAGGTGGGCGGTTCGCTGGGCCTGGCCACGCTGAGCACCGTGGCGGCCGACTCCACCCGGGACGCCCTGCCCGCCGGCCGCCCGCCGACCCGCCCGCAGCTCGCCCACGCGCTGGCCGAGGGCTGGGCCACGGCCCTGTCCGTCAGCGTGGCCTTCGTCGGCTGCGCGCTGGTCCTCGTCGTGGCCGTGATCCGCGCCCGGCCGCGCGCCGCCGAGCCCGCCACACGGCAGGAGGCGGTCACCCGCACCCCGGGCTGA	MDVTQDPAPPPRFWWAILVIAGAQLMVVLDISIVNIALPSIRDDLGFTRSGLQWVVNGYTLAFGGLLLFGGRVGDLLGRRRVFACGVCAFALISLLGGFADGPGRLIAARAAQGVAGALVAPTALALISTTFPEGRQRRAAFGVYGAVSAGGGAIGLLLGGLLTDTLSWRWVLWVNVPIGAALACGALLVLPSSARRGGRFDLPGALSVTGGLTALVYGLVRAPQHGWADRWTLTSFAAAAGLLVLFVLIEVRGRQPLMPLRVFADRDRSGAYAVTLLTGAALLSTLFFLAQFAQDVMGYSPLRNGVAFLPNAACVLLFSGLAARLTARVGAMPLMAAGAASMALGLAWLSRLDVGARYAADLLPGLLLYGSGLGLLFVPLSMTAVATVADEDSGLASGLLNTAQQVGGSLGLATLSTVAADSTRDALPAGRPPTRPQLAHALAEGWATALSVSVAFVGCALVLVVAVIRARPRAAEPATRQEAVTRTPG	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	92.45	gnl|BL_ORD_ID|2188|hsp_num:0	2427			138	1386	rifampin; isoniazid
BGC0001366.1|BE-24566B_6 # 5743 # 6168 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.721	BGC0001366.1|BE-24566B_6 	5743	6168	+	Loose	500	23.8682	FomB	43.75	3000449	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	Fom phosphotransferase family	GTGACCGCACAGCCTGTCCCCGTCGTCTCGCTGGACGACGCCTTGCCCAACCGCCGGCGCGGCGGGGATCTGCGCACCCTGCTCAGCCCCAAGACGGTCGGCGCCACCTCCGGCTTCCTCGGCGTGGCGCTCATCGAGCCCGGCGAATACGTGGCCGAGCACTACCACCCCTACTCCGAGGAGTTCCTGTACGTGGTGTGCGGCGACCTCGTGGTCGACCTCGACGGCACGCCGTGCGAACTCCACGCCGACCAGGGGCTGATGGTCCCGGTCGGGATGCGCCACCGCGTGCGCAACACCGGAGCCGTGCAGGCCAGGATCGTCTTCCACCTCTCCCCGCTGGCCCCGCGCCCGGAACTGGGCCATGTGGACACCGAGACGGTCCCCTCCCCGGCCACAGGCACGCTCGCCCGGGAGGGGCGGTGA	MTAQPVPVVSLDDALPNRRRGGDLRTLLSPKTVGATSGFLGVALIEPGEYVAEHYHPYSEEFLYVVCGDLVVDLDGTPCELHADQGLMVPVGMRHRVRNTGAVQARIVFHLSPLAPRPELGHVDTETVPSPATGTLAREGR	MLENLTIRSSRVVDLNLVKVRLSTNLEDFAAYSYFSAFAEDESAPADYEVVCVDLDRDDIPAELYADRTDRTFRGKRFKGGYYLVHYFGEPAHLITVGRTFYVFGRSLEKTVWPYFVKHILTVHSADHGFLHLKAAGFELPGAGATLLVGRNGAGKTVFLAQACLNGARFLSNTHTLVRDGVAHGVPSSIRVRRDQCFGELIDKHDLTAHMESGDYVTDSSTLFESPQISTARVRNVVIVDYDPARPQGLMPISPAAAGTFMEQFSFAVTTYGLKDDLLAHHGDFDTYVDSLARMRAQLTELVEGARCYRANADMLAKEVRDSTLKQLAE	42.73	gnl|BL_ORD_ID|1708|hsp_num:0	1850			147	237	fosfomycin
BGC0001366.1|BE-24566B_8 # 7427 # 8707 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.765	BGC0001366.1|BE-24566B_8 	7427	8707	+	Loose	750	106.301	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.13	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGACCCCCGCGGCCGGGCCGGCCACGCGCACCGCCACCGCCGTCATCACGGGTCTGGGCATCGTCGCGCCGGGCGGCATCGGCGTCGATGAGTACTGGTCGGCGATGCTGCGCGGACACAGTGCCATCGGCCCCATCACCCGCTTCGACGCCTCCGGCTATCCGGTGCGGCTGGCCGGCGAGGTGTCCGGCTTCCGCACCGAAGAGCGCATCCCCAGCAGGCTGGCCGTCCAGACCGACCGCTGGACCCACCTTGGCCTGGCCGCCGCGGAGGCCGCGCTCGCCGACGCCGGGGCGGGCCCGGGCACCCTGACGGAAAGACCCCAGCAGTTCGGACTGTCCGAATACGACATGGCGGTCGTGACCGCCTCCTCCTCCGGCGGCACCGAGTTCGGGCAGCGGGAGATCGAACGGCTGTGGTCGCGCGGGCCCCGGCACGTCGGCGCGTACCAGTCGATCGCCTGGTTCTACGCCGCGACCACCGGCCAGATTTCCATCCGCCACGGCATGCGCGGGCCGTGCGGGGTCATCGCGGCCGAGCAGGCCGGCGCCCTGGACGCGCTCGCGCACGCCCGCCGGGTGGTGCGCGACGGCGCCCGGCTCGTGGTCAGCGGCGGCACCGACGCCTCGCTGTGCCCGTACGGTCTCGTCGCCCAGCTCTCCAGCGGCCGGCTGTCCACCCGCGAGGACCCGGCACGGGCCTATGTGCCCTTCGACGCCGGGGCCTGCGGCCACCTCCCGGGCGAGGGCGGGGCGATGCTGATCGTCGAGGACGCCCGCTCGGCCCGGCGGCGCGGCGCCGCCCACGCGTACGGCGAGATCGCCGGGCACGCGGCCACCTTCGACCCGCCACCCGGCTCCGGCCGTGAGCCCGGGTTGCGCCGCGCCGTCATGAACGCCCTGATCGACGCCCGGATGGCGCCGGAGGAGATCGACGTCGTCTTCGCCGACGCCGCCGCCGTACCCGCCCTCGACCGCGCCGAGGCGGACGCCCTCGCCTGGGTCTTCGAGCCGTACGGCGTGCCCGTCACCGCGCCCAAGACGCTGACCGGCCGGCTCTACGCGGGCGCCGCGCTGGACGTGGCCACCGCGCTGCTGGCCATGCGCGACGACGTCATCCCGCCCACCGCGGCCGGGGTGACCCCGCACCCCGACCACCGGCTCGACCTGGTGGTGGGCGAGCCGCGGCCCGGCCCCGTACGGGCGGTCCTGGTGGCCGCCCGGGGCTTCGGCGGCATGAACGCCGCGCTGGTCCTGCGCCGGACGGACCCGCGCGGATGA	MTPAAGPATRTATAVITGLGIVAPGGIGVDEYWSAMLRGHSAIGPITRFDASGYPVRLAGEVSGFRTEERIPSRLAVQTDRWTHLGLAAAEAALADAGAGPGTLTERPQQFGLSEYDMAVVTASSSGGTEFGQREIERLWSRGPRHVGAYQSIAWFYAATTGQISIRHGMRGPCGVIAAEQAGALDALAHARRVVRDGARLVVSGGTDASLCPYGLVAQLSSGRLSTREDPARAYVPFDAGACGHLPGEGGAMLIVEDARSARRRGAAHAYGEIAGHAATFDPPPGSGREPGLRRAVMNALIDARMAPEEIDVVFADAAAVPALDRAEADALAWVFEPYGVPVTAPKTLTGRLYAGAALDVATALLAMRDDVIPPTAAGVTPHPDHRLDLVVGEPRPGPVRAVLVAARGFGGMNAALVLRRTDPRG	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|1968|hsp_num:0	1943			321	1245	isoniazid
BGC0001366.1|BE-24566B_9 # 8725 # 8982 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.651	BGC0001366.1|BE-24566B_9 	8725	8982	+	Loose	450	24.6386	lnuG	34.62	3004085	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGACCGAATTCACCATCGACGACCTGAGGCGGATCATGCGCGGCAGCGCGGGGGCCCAGGACGGGGAGCGCATCGACGGGGAGAACCTCGACGCCGACTTCGCCGACCTCGGCTACGACTCGCTGGCCGTACTGGAGATCCAGTCGCAGATCGAGAACACCTTCGACCTGACGCTGCCCGACGACGCCCTCAGTCGGATGCGCACCCCACGGCAGACCGTCTCCGTGGTCAACGCCTGTATCGGAAAAGAGGAGTGA	MTEFTIDDLRRIMRGSAGAQDGERIDGENLDADFADLGYDSLAVLEIQSQIENTFDLTLPDDALSRMRTPRQTVSVVNACIGKEE	MLKQKELMARVKELVQSDERISACMMYGSFTKGEGDQYSDIEYYVFLKDDTISTFDSAKWLNEVASYTLLYQNEYGTEVVIFENLIRGEFHFLSENEMNIIPSFKESGYIPDTKAMFIYDETGQLELYLSELEGPGPNRLTEENVNFLLNNFSNLWLMGINVLKRGENARSLELLSQLQKNILQLIRIAEENADNWFNMTKNLEKEISPENYEKFKKTTARLNELELYEAYKNSLLLVMELRNLVEKQYQLTISDDFLGKLFNYMNE	31.84	gnl|BL_ORD_ID|2380|hsp_num:0	2749			705	783	lincomycin
BGC0001366.1|BE-24566B_10 # 8991 # 9494 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.681	BGC0001366.1|BE-24566B_10 	8991	9494	+	Loose	690	27.7202	MexJ	40.62	3003692	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGAAGCGACCGAAGCGACCACAGCGACTGAACCGACTGAGCATGCCCGCACCGACAACTCCATCGTCATCGACGCGCCCCTGGAGCTGGTCTGGGACATCACGAACGACGTCGAGAACTGGCCGCGGCTGTTCAGCGAGTACGAGACGGCCGAGATCCTCCACCGGGACGGCGACACCATACGGTTCCGCCTCACCATGCACCCGGACGAGAACGGCACCAGCTGGAGCTGGGTGTCCGAGCGCACCGCGGACCCGGCCACCCATACCGTCCGCTCCCGCCGCGTCGAGACGGGCCCCTTCGCATTCATGGACATCTTCTGGGAGTTCACCCCGGAGCCCGAAGGGGTGCGCATGCGCTGGGTCCAGGAGTTCCACATGTCGCCCCAGGCCCCCGCCGACGACGCCGCCATGACCGCGCACATCAACCGCAACACCAGGATCCAGATGGCGCTGATCCGCGACCGGATCGAGGCCCGCGCCCGCGCGGCGGCCTCCTGA	MTEATEATTATEPTEHARTDNSIVIDAPLELVWDITNDVENWPRLFSEYETAEILHRDGDTIRFRLTMHPDENGTSWSWVSERTADPATHTVRSRRVETGPFAFMDIFWEFTPEPEGVRMRWVQEFHMSPQAPADDAAMTAHINRNTRIQMALIRDRIEARARAAAS	MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE	45.50	gnl|BL_ORD_ID|2015|hsp_num:0	2205			879	963	erythromycin; tetracycline; triclosan
BGC0001366.1|BE-24566B_11 # 9541 # 9882 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.681	BGC0001366.1|BE-24566B_11 	9541	9882	+	Loose	900	26.5646	emrY	33.33	3000254	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCACGACCTTGATCGTCGCCCGGCTGAAGCCCGGCGACCACCACGCCGCGATCAGCAGCCTGTTCGCGGAGTCGGACGCCACCGAACTGCCCGACCTGGTGGGCGTCCAGGAGCGGCGGCTGCTGACCTTCCAGGACCTGTACTTCCACCTCGTCCGCACGGACGAGGCCCTCTCCAAGACCCTCACCCCGCAACACGACAATCCGCTGTTCCGGTCGATCAGCCAGGCGATGGACGAGTACGTCACCCCGTACGAGGGCGCCTGGGGCAGCGTCCAGGAGGCCTCGGCCCGGCAGTTCTACCACTGGAAGCGCGGCATCGGCCAGGTCCAGTCCTGA	MATTLIVARLKPGDHHAAISSLFAESDATELPDLVGVQERRLLTFQDLYFHLVRTDEALSKTLTPQHDNPLFRSISQAMDEYVTPYEGAWGSVQEASARQFYHWKRGIGQVQS	MAITKSTPAPLTGGTLWCVTIALSLATFMQMLDSTISNVAIPTISGFLGASTDEGTWVITSFGVANAIAIPVTGRLAQRIGELRLFLLSVTFFSLSSLMCSLSTNLDVLIFFRVVQGLMAGPLIPLSQSLLLRNYPPEKRTFALALWSMTVIIAPICGPILGGYICDNFSWGWIFLINVPMGIIVLTLCLTLLKGRETETSPVKMNLPGLTLLVLGVGGLQIMLDKGRDLDWFNSSTIIILTVVSVISLISLVIWESTSENPILDLSLFKSRNFTIGIVSITCAYLFYSGAIVLMPQLLQETMGYNAIWAGLAYAPIGIMPLLISPLIGRYGNKIDMRLLVTFSFLMYAVCYYWRSVTFMPTIDFTGIILPQFFQGFAVACFFLPLTTISFSGLPDNKFANASSMSNFFRTLSGSVGTSLTMTLWGRRESLHHSQLTATIDQFNPVFNSSSQIMDKYYGSLSGVLNEINNEITQQSLSISANEIFRMAAIAFILLTVLVWFAKPPFTAKGVG	22.07	gnl|BL_ORD_ID|491|hsp_num:0	540			1308	1425	tetracycline
BGC0001366.1|BE-24566B_12 # 9901 # 11211 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.695	BGC0001366.1|BE-24566B_12 	9901	11211	+	Loose	550	51.9878	Nocardia farcinica rox	28.07	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGACACACTCAATGGACACGACAGACACAGGCGACCCCGGTACCTCCTACGACGTCGTTGTGATCGGCGGCGGCCCCGCCGGCTCGAGCACCGCGGCCCAGCTGGCCCGGGCCGGCCACCGGGTGCTGGTGCTGGAGCGGGAGAAGTTCCCCCGCTACCACATCGGCGAGTCCCTCATCCCCGGCTGCCTCGACCTGGTCAGGGACCTGGGCCTGTGGGACCGGCTGGAAGGCCTCGGCTTCACCAAGAAGTACGGCGGCACCCTGCTGTGGGGCGCCACCGAGGGCACCTGGGACTTCCGGTTCGCCGACGGCAGCGACTACGAGTACTCCTTCCAGGTGCGCCGCGCCGACTTCGACGCCCTGCTGCTCACCCGCGCCCGGGAGCTCGGCGCCCGGGTGGTCGAGGAGGCCACGGTCAAGGACGTGGAGTTCGACGGCGACCGCGCCACCGGCCTGGTCTACACCGTCAAGGGCTCGGACGAGCCCGTACGGGTCTCCTCCCGCTTCCTCGTCGACGCCTCCGGACAGCAGCGGCTCCTCGGCCGCCGGCTCGGGCTCGTCGACTGGCACGAGGACCTGCGCAATGTCGCGGTGTGGAGCTACTTCCAGGGCTGCGACTTCATCGAGGGCGAGAACCGGGCCGGCGACGTGGTCGTGGAGAACATGTGGCAGGAGGACCAGCCTCCCGGCTGGTTCTGGTTCATCCCGCTGCACGACGGCACGGTCAGCATCGGCTATGTCACCCGCACCGCTCTGCTGCAGCGCTCCGGTCTGACCCCGGACCAGCTGTTCGAACAGCAGCTGGCCGCCTCGGACGAGGTCAAGCGGCTCACCCGGAACGCCACCAGGACCAGCGCCTACCGCACCCTGCGCGACTGGAGCTATGAGTGCACCCGCTTCCATGGCCCCGGCTGGGCCGTGGTCGGCGACGCCGCGGCCTTTGTCGACCCGCTGTTCTCCACCGGCGTCACCCTGGCCATGCGCGGTGCGCGGGACCTGGCCCCCGCGGTCGACCAGGCGCTGCGCGACCCGGGCCAGGAGGCCGATCTGCTCAAGGCGTACGAGGACGGGTACCGCGAATTCCTCGGCCACGTCCTGACCTTCGTGCGCTTCTTCTACAACATCAAGATGCACAAGGAACAGTACTGGGAGGGCGCCCAGACCATCGTCGACCCGCAGAAGCTCCAGGCGCCGAAGATCGACTTCGCGGTCCTGCTGGCCGGCATGACCGGCATCCGGCCCACGCCCGAGATGCAGGCGGACGCCAGGGCCAAGACCAACGACATCCACTCCCGCTTCGCGACATGA	MTHSMDTTDTGDPGTSYDVVVIGGGPAGSSTAAQLARAGHRVLVLEREKFPRYHIGESLIPGCLDLVRDLGLWDRLEGLGFTKKYGGTLLWGATEGTWDFRFADGSDYEYSFQVRRADFDALLLTRARELGARVVEEATVKDVEFDGDRATGLVYTVKGSDEPVRVSSRFLVDASGQQRLLGRRLGLVDWHEDLRNVAVWSYFQGCDFIEGENRAGDVVVENMWQEDQPPGWFWFIPLHDGTVSIGYVTRTALLQRSGLTPDQLFEQQLAASDEVKRLTRNATRTSAYRTLRDWSYECTRFHGPGWAVVGDAAAFVDPLFSTGVTLAMRGARDLAPAVDQALRDPGQEADLLKAYEDGYREFLGHVLTFVRFFYNIKMHKEQYWEGAQTIVDPQKLQAPKIDFAVLLAGMTGIRPTPEMQADARAKTNDIHSRFAT	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	92.18	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	489	rifampin
BGC0001366.1|BE-24566B_14 # 11554 # 12585 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.718	BGC0001366.1|BE-24566B_14 	11554	12585	+	Loose	500	33.4982	chrB	45.16	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGACCGACACCGACTACACCCCCGAGCTGGCGACCGCGGCCCGGGTGAAGGAACTGGCGATGGGCCTGTGGGTCTCCGCCATGATGATGACGGCCGTTCAGCTGCGGATCCCCGACGAGATCGATGACAAGCCGGTCGAGGCGGGCGAGCTCGCCGCCCGGCTGGACCTGCACCCCGAGGCCCTCGCCCGGTTGCTGCGGGCGCTGGCCGCGCACGGCGTCTTCACGGAGGTGGCCGAGGACCGTTTCGGACACACCGAGCTCTCCCGGGTGCTCCGCGAGGACCACCCGAACAGCGTGCGCTACCAGGTGCTGTGGACCGTGGCCCCCTGGACCTGGCAGGCCTGGCCGCACCTGGGGGAGGCGGTGCGCACCGGCGAGCGGGTCTTCCCGCGCCTGTACGGCAAGGAGTTCTTCGCCTATCTCTCCCAGGACGCCCCGCAGTCCGCCGAGGTGTTCAACCGGGCCATGACCCAGTCCTCCGCCTTCACCTCGGCCATGGTCGCCGAGGCCCTGGACATGACCGGCGTACGCGTCGTGGTCGACGTCGGCGGCGGCCGCGGCCACCTGCTGCGCACCGTCCTGGAGCGGTACCCCTGGCTGAGCGGGGTGCTCTACGACCTGGCGCCCGTGGTGGCCTCCGCGGACCCCGCCCTGCGGCCCGGCGGCGAACTCGCCGACCGCGCCAAGGTGGTCGCGGGCAGCTGCCTGGACGGCGTCCCGCCCGGCGACCTCCACATCCTGAAGAACCTGCTGGAATGGGACGACGAACGGACCGTCACCACGCTGCGGCACGTGGCCGGGGCGCTGCGCTCGGGCGGCCGGGCGGTGCTGGTGCAGAACCTGGTCGACGACAGCCCCGAGCCCAAGGTCACCACCGGGATGGATCTGCTGCTGCTCCTCAACGTCGGCGGGAGGAAGCACACCAGGCGCCAGCTGACCCGGCTGCTGTCCGAGGCGGGCCTTGAGATCACCGAGATCCGTCCCACGGCCAGCAGCCTCTTCGTCATCGAAATCGCCCTGCGCGGCTAG	MTDTDYTPELATAARVKELAMGLWVSAMMMTAVQLRIPDEIDDKPVEAGELAARLDLHPEALARLLRALAAHGVFTEVAEDRFGHTELSRVLREDHPNSVRYQVLWTVAPWTWQAWPHLGEAVRTGERVFPRLYGKEFFAYLSQDAPQSAEVFNRAMTQSSAFTSAMVAEALDMTGVRVVVDVGGGRGHLLRTVLERYPWLSGVLYDLAPVVASADPALRPGGELADRAKVVAGSCLDGVPPGDLHILKNLLEWDDERTVTTLRHVAGALRSGGRAVLVQNLVDDSPEPKVTTGMDLLLLLNVGGRKHTRRQLTRLLSEAGLEITEIRPTASSLFVIEIALRG	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	122.50	gnl|BL_ORD_ID|274|hsp_num:0	305			273	366	tylosin; chalcomycin; mycinamicin
BGC0001366.1|BE-24566B_15 # 12582 # 14057 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0001366.1|BE-24566B_15 	12582	14057	-	Loose	1100	31.187	tetA(60)	26.42	3004035	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAGTGGTTCACCTCATCCGACTACTGGCTGAGCCGACTGGTCTTCCAACGCGGCCTGGCGGCCCTCTATCTGATCGCCTTTGTGGTCGCGGCGAACCAGGGGCGGGCCCTGATCGGCGAGCGGGGCCTGACGCCGGTGCCGCGGTTCACCGCGCGGATGCCGTTCCGGCGCTCCCCGAGCCTCTTCCACCTCCACTTCTCGGACCGCTTCTTCACCGGCTGCGCCTGGCTGGGGGCCGCGCTCGCCGCCGCGGTGGTGGCGGGGGCCGCGGACCGGGTGCCGCTGTGGGCCGCGATGCTGATGTGGCTGGTGCTGTGGCTGCTGTATCTGTCGATCGTCAACGTGGGGCAGGTGTGGTACGGGTTCGGCTGGGAGTCCCTGCTGCTGGAGAGCGGCTTCCTCGCCGTCTTCCTCGGCAACGCCCGTACCGCCCCGCCGGTCCTGGTGCTGTGGCTGCTGCGCTGGCTGCTGTTCCGGGTCGAGTTCGGCGCCGGGCTGATCAAGATCCGGGGCGACCGCTGCTGGCGGCAGCTGACCTGTCTGTACTACCACCACGAGACACAGCCGATGCCGGGCCCGCTGAGCTGGTTCTTCCACCGGCTGCCGGGGCCCTTGCACCGGGTCGAGGTGGCGGCCAACCACGTCGCCCAATTGGTCGTGCCCCTCGCGCTGTTCGCGCCGCAGCCGGGGGCAAGCGTGGCCGGGGCCGTGATCGTGGTCACCCAGCTGTGGCTGGTCGCGTCCGGCAACTTCTCGTGGCTGAACTGGGTGACCATCGTGCTGGCCCTCGCCGCGGTCGACGGGCGGCTCGCGGCCCAGGCGCTGGGACTGCCCGAGCCGCCGCCGCTCGCCGGTCCCCCGGTGTGGTTCGAGGCCCTGGTGCTGGCTGCCACCGCTCTGGTGGTGGTGCTCAGCTACTGGCCCGCCCGGAACCTGGTGTCGGGCAGTCAGCTGATGAACTACTCCTTCAATCCGCTGCACCTGGTCAACACCTACGGCGCCTTCGGCAGCGTCAACCGCGCCCGGTTCGAGGTGGTGATCCAGGGCACCGACGAGCCGCTGCCCACGTCGGACACGGTGTGGAAGGAGTACGAGTTCCGGGGCAAGCCCGGCGATGTGCGCCGGATGCCGCGCCAGTTCGCCCCGTACCACCTGCGCCTCGACTGGATGATGTGGTTCGCCGGGATCTCGCCGGCCTACGCCCGGTCCTGGTTCGGCCCGCTGGTCACCAAGCTGCTGGAGGGCGACCCGGCGACGCTGAAGCTGTTGCGGGTGTGCCCCTTCCCCGACGCGCCGCCTGCTTACATCCGCGCCCGCCTGTTCCTGTACCGCTTCACGACCTGGAGTGAGTTGCGGGCCACCGGCGCGTGGTGGCACCGCACGCTCATCCGCGAGTTCCTGCCCCCGGTCGCCCTCGACCGTCCGGACCGGCAGGGCGACCGCCCGGACGGGACCCGGGGCGGGACGGGCTAG	MEWFTSSDYWLSRLVFQRGLAALYLIAFVVAANQGRALIGERGLTPVPRFTARMPFRRSPSLFHLHFSDRFFTGCAWLGAALAAAVVAGAADRVPLWAAMLMWLVLWLLYLSIVNVGQVWYGFGWESLLLESGFLAVFLGNARTAPPVLVLWLLRWLLFRVEFGAGLIKIRGDRCWRQLTCLYYHHETQPMPGPLSWFFHRLPGPLHRVEVAANHVAQLVVPLALFAPQPGASVAGAVIVVTQLWLVASGNFSWLNWVTIVLALAAVDGRLAAQALGLPEPPPLAGPPVWFEALVLAATALVVVLSYWPARNLVSGSQLMNYSFNPLHLVNTYGAFGSVNRARFEVVIQGTDEPLPTSDTVWKEYEFRGKPGDVRRMPRQFAPYHLRLDWMMWFAGISPAYARSWFGPLVTKLLEGDPATLKLLRVCPFPDAPPAYIRARLFLYRFTTWSELRATGAWWHRTLIREFLPPVALDRPDRQGDRPDGTRGGTG	MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQLVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITRSSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTEIESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE	84.80	gnl|BL_ORD_ID|2310|hsp_num:0	2645			1128	1419	tetracycline
BGC0001366.1|BE-24566B_16 # 14222 # 15268 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.752	BGC0001366.1|BE-24566B_16 	14222	15268	-	Loose	960	26.1794	cmeC	33.87	3000785	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACAGCGAGGTCACGGCGGGGCCACCGCGGCGCGTCACCATCAAGGACGTCGCCGCGCGGGCCGGGGTCTCCAAGGGCGCGGTCTCGCTCGCCTTCAACGACCGCCCGGGCGTCTCCCAGGCCACCCGGGCCCGGATCTTCGAGGCCGCCCGGGAGCTGGGCTGGGCGCCCCATCTCTCCGCCCGGTCGCTGTCCAACGCGCGGGTGGACGCCGTGGGCCTGGCCATCGCCCGGCCGGCCCGGATGCTGGGGCTGGAGCCGTGGTTCATGGAGTTCGTCTCGGGCATCGAGAGCGTGCTCGTCGAGCGGTCCTGCTCGCTGCTGCTGCGGCTGGTGCGGGACGTGCGGGAGGAGATCGCGGTCCAGGAGGCGTGGTGGCGGGGGCGGCAGGTCGGCGGGTCGATTCTCGTCGACCTCCACGACGGGGATCCGCGCGTCCCCGAGCTGCGCCGGCTCGGGGTGCCCGCCGTGGCCGCCGGGCACCCGTCCCTGGCCGGGGGCTTCACCTGTGTATGGACCGACGACGGCACCGCTGTCACGGAGGCGGTGCGCTATCTGGCGGCGCTGGGCCACCGGCGGATCGCCCGGGTGAGCGGCCCCGCCACGCTGGGGCACAGCGTGATCCGTACCGCCGCCTTCGAGGCGGCCGTACGGGAACTGGGGCTGGCCGACGGGCGCACGGTCGCCACCGACTTCTCGGGTGAGGAGGGGGCGCGCGCCACGCGGGCGCTGCTGGCCTCGGCCGACCGGCCGACGGCGGTCATCTACGACAACGACATCATGGCGGTGGCGGGCCTGTCGGTGACCGCCGAGATGGGTCTTGCGGTTCCGGTCGACGTCTCGCTGCTGGCCTGGGACGACTCCCAGCTGTGCCAGCTCACCCGCCCCACGCTGTCGGCGATGAGCCATGACGTCTTCGGCTTCGGGGCCGAGGTCGCCCGCCGCCTGTTCGATGTGCTCGGCCAGGCGGCGCCCAGCACCCACCAGGCGCCCACCCCGGCGCTCACCCCGCGCGGCAGCACCGCCCCGCCACGGCGGCCCTGA	MDSEVTAGPPRRVTIKDVAARAGVSKGAVSLAFNDRPGVSQATRARIFEAARELGWAPHLSARSLSNARVDAVGLAIARPARMLGLEPWFMEFVSGIESVLVERSCSLLLRLVRDVREEIAVQEAWWRGRQVGGSILVDLHDGDPRVPELRRLGVPAVAAGHPSLAGGFTCVWTDDGTAVTEAVRYLAALGHRRIARVSGPATLGHSVIRTAAFEAAVRELGLADGRTVATDFSGEEGARATRALLASADRPTAVIYDNDIMAVAGLSVTAEMGLAVPVDVSLLAWDDSQLCQLTRPTLSAMSHDVFGFGAEVARRLFDVLGQAAPSTHQAPTPALTPRGSTAPPRRP	MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDFDDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAPSNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQTYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEAKLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEKLTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIYQNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAKERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIKEESKNLDMSFRE	70.73	gnl|BL_ORD_ID|731|hsp_num:0	798			258	435	erythromycin; cefotaxime; fusidic acid
BGC0001366.1|BE-24566B_7 # 6165 # 7430 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.731	BGC0001366.1|BE-24566B_7 	6165	7430	+	Loose	750	181.415	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.35	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGTCGCACCGCCGTCATCACCGGGATCGGGGTGGTGGCCCCCGGCGGAGTCGGCACCAAGGGCTTTTGGGAGCTGCTCATCTCCGGGCGCACCGCCACCCGGCGGATCTCCCTCTTCGACCCCACCGGATTCCGCTCCCAGGTGGCCGCCGAATGCGACTTCGACCCCGCCGCCGAAGGACTGAGCCCGCAGGAGATACGCCGGATGGACCGGGCCGCCCAGTTCGCGGTCGCCGCGGTGAGGGAAGCGCTCGCCGACAGCGGGCTGACCCCCGCCGAGGCGCCCGCGCACCGCACCGGCGTGAGCCTGGGCAGCGCCGTCGGGTGCACCACGGGACTGGAGGAGGAGTATGTCGTCCTGAGCGACGGCGGCCGGCTCCACCTGGTCGACCACCGCTACAAAGTCCCCGAGCTGTACGGGTACATGGTGCCCAGCACGCTTGCCGTCGAGACGGCGTGGGCGTGCGGCGCCGAGGGCCCGGTCGGCCTGATCTCCACCGGCTGCACCTCGGGTCTCGACGCCGTCGGCTACGGCGCCCAGCTCATCGCCGAGGGCTCGGCCGACGTGATGGTCGCGGGCGCCACCGACGCGCCCATCTCGCCCATCACCTCGGCCTGCTTCGCCGCCATCAAGGCCACCTCGCCCAACAACGACGACCCGGCCCACGCCTCCCGCCCCTTCGACCGCCTGCGGGACGGCTTCGTCCTTGGCGAGGGCGCGGCCGTGATGGTGCTGGAGGAGCGCGGCCGAGCCGAGGCCCGGGGCGCTCATGTCTACGCCGAGCTCGCGGCCTTCGCGAGCCGCAGCAACGCCTTCCACATGACCGGACTGCGCCCCGACGGCCGGGAGATGGCCGAGGCCATCCGGGTCGCCCTGGACCGGGCCCGCCTCGCGCCGGGCGATGTCGACTACATCAACGCGCACGGCTCCGGCACCCGCCAGAACGACCGCCACGAAACCGCCGCCTTCAAGCGCGCGCTGGGCGAGCGGGCCCGCGAGGTGCCCGTCAGCTCCATCAAGTCCATGGTCGGCCACTCGCTCGGGGCGATCGGCGCGATCGAGGTCGCCGCCTGCGCGCTGGCGCTGGAACACCAGGTCGTGCCGCCCACCGCCAATCTGCACCACCCCGACCCCGAATGCGACTTGGACTACGTCCCGCTGACGGCCCGTGACCACACCATGGACGTGGTGCTCTCGGTCGGCAGCGGCTTCGGCGGCTTCCAGACGGCGATGCTGCTCAGCCGGCCCGGGAGGGCCCGGTGA	MSRTAVITGIGVVAPGGVGTKGFWELLISGRTATRRISLFDPTGFRSQVAAECDFDPAAEGLSPQEIRRMDRAAQFAVAAVREALADSGLTPAEAPAHRTGVSLGSAVGCTTGLEEEYVVLSDGGRLHLVDHRYKVPELYGYMVPSTLAVETAWACGAEGPVGLISTGCTSGLDAVGYGAQLIAEGSADVMVAGATDAPISPITSACFAAIKATSPNNDDPAHASRPFDRLRDGFVLGEGAAVMVLEERGRAEARGAHVYAELAAFASRSNAFHMTGLRPDGREMAEAIRVALDRARLAPGDVDYINAHGSGTRQNDRHETAAFKRALGERAREVPVSSIKSMVGHSLGAIGAIEVAACALALEHQVVPPTANLHHPDPECDLDYVPLTARDHTMDVVLSVGSGFGGFQTAMLLSRPGRAR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.20	gnl|BL_ORD_ID|1968|hsp_num:0	1943			195	1245	isoniazid
